# Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/improved-survival-and-complete-response-rates-in-patients-with-advanced-melanoma/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kristian Michael Koller,Heath B. Mackley,Jason Liu,Henry Wagner,Giampaolo Talamo,Todd D. Schell,Colette Pameijer,Rogerio I. Neves,Bryan Anderson,Kathleen M. Kokolus,Carol Mallon,Joseph J. Drabick |
| Citations | 157 |
| DOI | 10.1080/15384047.2016.1264543 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/15384047.2016.1264543?needAccess=true&role=button |
| OpenAlex ID | https://openalex.org/W2557794937 |
| PMID | 27905824 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Giampaolo Talamo](https://scholariq.org/researchers/giampaolo-talamo/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.